Official 2024 U.S. DOL Form 5500 summary for Glaxosmithkline LLC (Gsk 401(k) Plan · EIN 23-1099050 · PN 002): $8.79B net assets, 12,254 active participants, and $9.01 per $10,000 (9.01 bps).
| Plan Sponsor | Glaxosmithkline LLC |
|---|---|
| Filing Identifier | Gsk 401(k) Plan · EIN 23-1099050 · PN 002 |
| Plan Category & State | 401(k) Defined Contribution (PA) |
| Asset-Size Peer Cohort | >$1B |
| Plan Net Assets (2024) | $8.79B |
| Active Participants | 12,254 |
| Direct Admin Fee Rate | $9.01 per $10,000 (9.01 bps) |
| Cohort Peer Median | $4.40 per $10,000 (4.40 bps) |
| Primary Recordkeeper / Provider | Alight Solutions |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI
Verified federal filings reconciled for GSK across sibling Meru AI platforms.